INT17804

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.31
First Reported 1991
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 2
Total Number 4
Disease Relevance 2.03
Pain Relevance 0.85

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

transport (Ambp) extracellular region (Ambp) plasma membrane (Ambp)
protein maturation (Ambp)
Anatomy Link Frequency
blood 1
ear 1
urine 1
Ambp (Mus musculus)
Pain Link Frequency Relevance Heat
anesthesia 40 99.18 Very High Very High Very High
cva 19 98.48 Very High Very High Very High
Inflammation 39 98.36 Very High Very High Very High
withdrawal 1 83.92 Quite High
cytokine 21 82.32 Quite High
Catecholamine 1 78.40 Quite High
Inflammatory response 6 5.00 Very Low Very Low Very Low
aspirin 3 5.00 Very Low Very Low Very Low
Versed 3 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Pressure Volume 2 Under Development 69 98.96 Very High Very High Very High
Hemorrhage 46 98.48 Very High Very High Very High
INFLAMMATION 45 98.36 Very High Very High Very High
Postoperative Hemorrhage 18 93.40 High High
Pancreatitis 3 84.00 Quite High
Syndrome 3 79.92 Quite High
Disseminated Intravascular Coagulation 9 76.96 Quite High
Multiple Organ Failure 3 72.96 Quite High
Shock 3 61.72 Quite High
Acute-phase Reaction 3 60.72 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Microcirculation during excessive hemorrhage and fluid therapy under anesthesia with or without associated treatment by ulinastatin (urinary trypsin inhibitor) was studied by using the rabbit ear chamber.
Negative_regulation (inhibitor) of ulinastatin in ear associated with anesthesia and cva
1) Confidence 0.31 Published 1991 Journal Masui Section Abstract Doc Link 1942513 Disease Relevance 0.24 Pain Relevance 0.32
Ulinastatin (UlistinĀ®, Han Lim Pharmaceutical, Seoul, Korea), a urinary trypsin inhibitor, is a glycoprotein derived from human urine [12].
Negative_regulation (inhibitor) of Ulinastatin in urine
2) Confidence 0.14 Published 2010 Journal Korean Journal of Anesthesiology Section Body Doc Link PMC2872884 Disease Relevance 0.93 Pain Relevance 0.28
Ulinastatin, a urinary trypsin inhibitor, is widely used to treat acute systemic inflammatory disorders.
Negative_regulation (inhibitor) of Ulinastatin associated with inflammation
3) Confidence 0.14 Published 2010 Journal Korean Journal of Anesthesiology Section Abstract Doc Link PMC2872884 Disease Relevance 0.18 Pain Relevance 0.10
In conclusion, a single infusion of ulinastatin during major orthopedic surgery reduces blood loss in the early postoperative period.
Negative_regulation (infusion) of ulinastatin in blood associated with pressure volume 2 under development
4) Confidence 0.14 Published 2010 Journal Korean Journal of Anesthesiology Section Body Doc Link PMC2872884 Disease Relevance 0.68 Pain Relevance 0.15

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox